Petra Bohanec Grabar

597 total citations
11 papers, 413 citations indexed

About

Petra Bohanec Grabar is a scholar working on Rheumatology, Public Health, Environmental and Occupational Health and Genetics. According to data from OpenAlex, Petra Bohanec Grabar has authored 11 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Genetics. Recurrent topics in Petra Bohanec Grabar's work include Rheumatoid Arthritis Research and Therapies (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Petra Bohanec Grabar is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (5 papers), Acute Lymphoblastic Leukemia research (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Petra Bohanec Grabar collaborates with scholars based in Slovenia and Spain. Petra Bohanec Grabar's co-authors include Vita Dolžan, D Logar, Blaž Rozman, Matija Tomšič, Iztok Grabnar, Barbara Faganel Kotnik, Janez Jazbec, Cristina Rodríguez‐Antona, Matija Tomšič and Lucía Inglada‐Pérez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Drug Metabolism and Disposition and European Journal of Clinical Pharmacology.

In The Last Decade

Petra Bohanec Grabar

10 papers receiving 398 citations

Peers

Petra Bohanec Grabar
Eric Helmer Belgium
Victor Hoffbrand United Kingdom
Luz Agana United States
R. C. Horns United States
Gretchen A. Radloff United States
Hoffbrand Av United Kingdom
Petra Bohanec Grabar
Citations per year, relative to Petra Bohanec Grabar Petra Bohanec Grabar (= 1×) peers Mélanie Primeau

Countries citing papers authored by Petra Bohanec Grabar

Since Specialization
Citations

This map shows the geographic impact of Petra Bohanec Grabar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Bohanec Grabar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Bohanec Grabar more than expected).

Fields of papers citing papers by Petra Bohanec Grabar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Bohanec Grabar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Bohanec Grabar. The network helps show where Petra Bohanec Grabar may publish in the future.

Co-authorship network of co-authors of Petra Bohanec Grabar

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Bohanec Grabar. A scholar is included among the top collaborators of Petra Bohanec Grabar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Bohanec Grabar. Petra Bohanec Grabar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kotnik, Barbara Faganel, Janez Jazbec, Petra Bohanec Grabar, Cristina Rodríguez‐Antona, & Vita Dolžan. (2017). Association between SLC19A1 gene polymorphism and high dose methotrexate toxicity in childhood acute lymphoblastic leukaemia and non Hodgkin malignant lymphoma: introducing a haplotype based approach. Radiology and Oncology. 51(4). 455–462. 15 indexed citations
2.
Grabar, Petra Bohanec, Luis J. Leandro‐García, Lucía Inglada‐Pérez, et al.. (2012). Genetic Variation in the SLC19A1 gene and Methotrexate Toxicity in Rheumatoid Arthritis Patients. Pharmacogenomics. 13(14). 1583–1594. 24 indexed citations
3.
Kotnik, Barbara Faganel, Iztok Grabnar, Petra Bohanec Grabar, Vita Dolžan, & Janez Jazbec. (2011). Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma. European Journal of Clinical Pharmacology. 67(10). 993–1006. 91 indexed citations
4.
Grabar, Petra Bohanec, et al.. (2009). Genetic polymorphisms modifying oxidative stress are associated with disease activity in rheumatoid arthritis patients.. SHILAP Revista de lepidopterología. 26(1). 41–8. 27 indexed citations
6.
Grabar, Petra Bohanec, D Logar, Matija Tomšič, Blaž Rozman, & Vita Dolžan. (2009). Genetic Polymorphisms Modifying Oxidative Stress Are Associated with Disease Activity in Rheumatoid Arthritis Patients. Disease Markers. 26(1). 41–48. 24 indexed citations
7.
Grabar, Petra Bohanec, D Logar, Matija Tomšič, Blaž Rozman, & Vita Dolžan. (2009). Genetic polymorphisms of glutathione S-transferases and disease activity of rheumatoid arthritis.. PubMed. 27(2). 229–36. 32 indexed citations
8.
Grabar, Petra Bohanec, et al.. (2008). Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. European Journal of Clinical Pharmacology. 64(11). 1057–1068. 105 indexed citations
9.
Grabar, Petra Bohanec, et al.. (2008). Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients. European Journal of Clinical Pharmacology. 64(9). 871–876. 59 indexed citations
10.
Grabar, Petra Bohanec, et al.. (1985). [Prolonged survival of skin allografts in rats by injection of serum or a serum fraction extracted from pregnant rats].. PubMed. 301(14). 653–8. 1 indexed citations
11.
Grabar, Petra Bohanec, et al.. (1985). [Inhibitory activity of allograft reactions in vivo and in vitro and anticomplement activity of alpha 2 macroglobulin produced during pregnancy].. PubMed. 169(9). 1371–8.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026